Showing results (211-220 of 285) with videos related to

Sort By:
Pageof 29
American Journal of Respiratory and Critical Care Medicine|March 20, 2012
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseBartolome R Celli, Nicholas Locantore, Julie Yates, et al.
Annals of the American Thoracic Society|October 27, 2020
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACTMark T Dransfield, Courtney Crim, Gerard J Criner, et al.
The European Respiratory Journal|December 11, 2020
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohortBartolome Celli, Nicholas Locantore, Julie C Yates, et al.
American Journal of Human Genetics|October 6, 2009
Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility geneDawn L DeMeo, Thomas Mariani, Soumyaroop Bhattacharya, et al.
Respiratory Medicine|June 25, 2013
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohortJoy Miller, Lisa D Edwards, Alvar Agustí, et al.
Human Genetics|January 10, 2013
Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibilityMateusz Siedlinski, Dustin Tingley, Peter J Lipman, et al.
Respiratory Research|August 20, 2014
DNAH5 is associated with total lung capacity in chronic obstructive pulmonary diseaseJin Hwa Lee, Merry-Lynn N McDonald, Michael H Cho, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infectionHao Chen, Donghang Zheng, Jeff Abbott, et al.
Pulmonary Therapy|November 17, 2020
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT TrialDavid M G Halpin, Gerard J Criner, Mark T Dransfield, et al.
Chest|October 8, 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialNicola A Hanania, David M Mannino, Gerard J Criner, et al.
Pageof 29